Login / Signup

Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis.

Yu-Jih SuHui-Ming ChenTien-Ming ChanTien-Tsai ChengShan-Fu YuJia-Feng ChenChun-Yu LinChung-Yuan Hsu
Published in: RMD open (2023)
Patients with rheumatoid arthritis may have different levels of risk of diabetes depending on the treatment options.
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • rheumatoid arthritis
  • adipose tissue
  • drug induced